A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations

ClinicalTrials.gov ID: NCT01290484

Public ClinicalTrials.gov record NCT01290484. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 10, 2026, 6:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Investigational Pilot Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

There is an unsatisfied medical need for a first-line treatment of lymphatic malformations with a good benefit/risk profile. Based on a patient experience in the institution, the investigators plan to verify whether or not the medication sildenafil has a beneficial effect on lymphatic malformations. The investigators plan to do this by treating patients with lymphatic malformations with the medication sildenafil for a 20 week period. This is an investigator initiated study funded by an Innovations in Patient Care grant and a SPARK grant.

Study identification

NCT ID: NCT01290484
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: Stanford University; Other
Enrollment: 7 participants

Conditions and interventions

Conditions

Lymphangioma

Interventions

Sildenafil Drug

Drug

Eligibility (public fields only)

Age range: 6 Months to 10 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 30, 2010
Primary completion: Mar 31, 2013
Completion: Nov 30, 2013
Last update posted: Jun 18, 2015

2010 – 2013

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Stanford University School of Medicine	Stanford	California	94305	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01290484, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 18, 2015 · Synced Sep 10, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01290484 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →